Previous Article | Next Article 
Journal of Clinical Microbiology, June 2001, p. 2254-2260, Vol. 39, No. 6
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.6.2254-2260.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Isolation and Characterization of Borrelia
burgdorferi Sensu Lato Strains in an Area of Italy Where Lyme
Borreliosis Is Endemic
Lorenzo
Ciceroni,1
Simonetta
Ciarrochi,1
Alessandra
Ciervo,1
Valeria
Mondarini,2
Francesco
Guzzo,2
Giuseppe
Caruso,3
Rossella
Murgia,4 and
Marina
Cinco4,*
Department of Bacteriology and Medical
Mycology, Istituto Superiore di Sanità, 00161 Rome,1 Division of Infectious
Diseases3 and Laboratorio di analisi
Chimico-Cliniche,2 "San Martino" Hospital,
Belluno, and Dipartimento di Scienze Biomediche, Laboratorio
delle Spirochete, Università di Trieste,
Trieste,4 Italy
Received 23 October 2000/Returned for modification 21 January
2001/Accepted 8 April 2001
 |
ABSTRACT |
Between 1993 and 1998, we isolated Borrelia
burgdorferi sensu lato from 55 of the 119 patients with
clinically diagnosed Lyme borreliosis who were admitted to "San
Martino" Hospital in Belluno, Veneto, an Adriatic region in
northeastern Italy where Lyme borreliosis is endemic. Upon
hospitalization, all patients presented erythema migrans. Isolates were
typed using ribosomal DNA PCR-restriction fragment length polymorphism
(RFLP) analysis of the rrfA-rrlB intergenic spacer. Of
the 41 isolates typed, 37 belonged to Borrelia afzelii,
2 to Borrelia garinii, and 2 to B.
burgdorferi sensu stricto. Pulsed-field gel electrophoresis,
performed on 21 strains (13 new isolates and 8 controls), revealed
different RFLP patterns within the B. garinii and
B. afzelii strains; among the five B. garinii strains and the 12 B. afzelii strains,
three or two different RFLP patterns were identified, according to the
restriction enzyme used. The protein patterns of the new isolates
confirmed their genotypic classification and revealed the level of
expression of some immunodominant proteins like OspA and other
characteristic Osps. These findings constitute the first report of such
a high recovery rate of B. burgdorferi from patients in
a very restricted area in Italy; they also indicate the predominance of
the genospecies B. afzelii in the study area and the
heterogeneity of the circulating strains.
 |
INTRODUCTION |
Lyme borreliosis (LB)
is an emerging tick-borne zoonosis caused by spirochetes of the
Borrelia burgdorferi sensu lato complex, which are usually
transmitted to the host by the bite of infected hard ticks of the genus
Ixodes. Nucleic acid and protein studies have revealed great
genetic and phenotypic differences among the borrelial strains
associated with LB. Based on these differences, B. burgdorferi was recently divided into a number of genomic species (3, 6, 20, 24, 28, 30, 35, 36, 37, 45). To date, four of
these species have been found to be associated with LB: B. burgdorferi, Borrelia garinii, Borrelia afzelii, and Borrelia bissettii (6, 42). Three of these
species are known to be present in Italy (11, 14, 15). In
addition another species was found in Italian ticks, Borrelia
valaisiana, whose pathogenicity for humans is still questionable
(16).
Several studies have indicated that the clinical manifestations of LB
may vary according to the specific infecting genomic species of
B. burgdorferi sensu lato: from patients affected by LB
arthritis, the most commonly isolated strains belong to B. burgdorferi sensu stricto, whereas B. garinii seems to
be involved in cases showing prevalent neurological manifestations.
Strains of B. afzelii have been found prevalent in skin
forms of the disease, erythema migrans (EM) and especially
acrodermatitis chronica athrophicans. (2, 5, 12, 44).
However, the distribution and the prevalence of the different species
within various geographic regions, which could provide information on
the epidemiology of LB, have still not been clearly defined.
Molecular techniques used for identifying and typing microorganisms can
be categorized as either phenotypic or genetic on the basis of the
macromolecular targets used for analysis. For B. burgdorferi
sensu lato, the phenotypic typing systems include sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of
proteins (33), profile analysis of fatty acids
(30), and serotyping (47, 48); the genetic
typing systems, which can provide more precise information on the
diversity of B. burgdorferi, include restriction enzyme
analysis (1, 27), DNA-DNA hybridization (27,
38), PCR-restriction fragment length polymorphism (RFLP) analysis of the rrfA-rrlB intergenic spacer
(36), plasmid profile analysis (7), PCR
(31), and arbitrarily primed PCR (46). Another molecular typing method, the pulsed-field gel electrophoresis (PFGE) of large DNA fragments produced by rare-cutting restriction enzymes, has provided results that are consistent with the division of
B. burgdorferi sensu lato into the genomic species and has been successfully used to differentiate closely related borrelial isolates (9, 14, 21, 22, 34).
Between 1993 and 1998, 119 persons with an illness consistent with LB
were admitted to "San Martino" Hospital in the city of Belluno,
which is situated in Veneto, an Adriatic region in northeastern Italy
where LB is endemic. Various cases of LB have been reported in the
Belluno area in recent years, and a recent tick-spirochete survey
identified Borrelia infection in 0.8% of the nymphs and
3.1% of the adult Ixodes ricinus ticks collected, in
addition to isolating two genomic species (i.e., B. burgdorferi sensu stricto and B. garinii) (L. Ciceroni,
S. Ciarrocchi, B. Carnielli, and M. Romano, Abstr. 8th Int. Conf. Lyme
Borrel. Other Emerg. Tick-Borne Dis. 1999, abstr. P-318, p. 85, 1999).
The aim of the present study, which was performed as part of an LB
survey in the Veneto region, was to identify the genospecies of the
borreliae isolated from these hospital patients: PCR-RFLP analysis of
the rrfA-rrlB intergenic spacer was directly applied to the
fresh culture, first passage, to identify the genospecies; PFGE was
subsequently applied to culture-adapted, cloned strains to further
assess their intraspecies heterogeneity. The results of genetic typing
were compared with the protein profiles of the isolates.
 |
MATERIALS AND METHODS |
Clinical samples and isolation of spirochetes.
The 119 persons were hospitalized between October 1993 and October 1998 and
were clinically diagnosed with LB on the basis of EM and other clinical
symptoms (13). Skin biopsies, performed for all patients
prior to antibiotic therapy, were taken near the margin of the EM and
inoculated in 5 ml of modified Barbour-Stoenner-Kelly (BSK) II medium
containing 5% normal rabbit serum. All specimens were incubated at
32°C for at least 2 months, and samples of each culture were examined
weekly for spirochetes by dark-field microscopy.
Borrelial strains and growth conditions.
As controls,
strains of six different genospecies of B. burgdorferi sensu
lato were used: B. burgdorferi sensu stricto (B31, IRS),
B. garinii (N34, G25), B. afzelii (VS461),
B. valaisiana (VS116), Borrelia lusitaniae (Poti
B1), and B. bissettii (DN127). We also used two local
strains as controls: B. garinii BZ5, isolated from I. ricinus ticks collected in the bordering area of Alto Adige-South
Tyrol, and B. garinii BITS, isolated from the nearby Karst
region (11, 17). The North American type strain B. burgdorferi sensu stricto B31 (from Ixodes dammini
ticks; Shelter Island, N.Y.) and the two I. ricinus strains
IRS (from Switzerland) and G25 (from Sweden) were kindly provided by
R. C. Johnson (University of Minnesota, Minneapolis). As for the
other reference strains, B. afzelii VS461, B. valaisiana VS116, B. lusitaniae Poti B1, and B. bissetti DN127 were obtained from D. Postic (Unité de Bactériologie Moléculaire et Médicale, Institut
Pasteur, Paris, France) and N34 was kindly supplied by R. Ackermann
(Department of Virology, University of Cologne, Cologne, Germany). The
B. garinii BZ5 strain was taken from our collection
(Istituto Superiore di Sanità). All spirochetes were grown in BSK
II medium at 32°C for 7 to 10 days (8).
PCR-RFLP analysis of the rrfA-rrlB intergenic
spacer.
PCR-RFLP analysis was performed on the first passage of
clinical samples showing borrelial growth. For the analysis, 2 ml of
culture was washed twice in phosphate-buffered saline and resuspended in 50 µl of distilled water. The preparation was boiled at 100°C for 10 min, and this suspension was used for PCR. Positive controls included strains B31, BITS, VS461, VS116, Poti B1, and DN127. Positive
control DNA was extracted as previously described (19); 1 ng of isolate DNA was used for each positive control. PCR amplification of the 5S-23S intergenic spacer DNA was performed as described by
Postic et al. (36). This was followed by endonuclease
MseI (Boehringer Mannheim, Mannheim, Germany) digestion,
performed according to the manufacturer's instructions. The
restriction fragments were subsequently subjected to electrophoresis on
a 16% acrylamide-0.8% bisacrylamide gel for 3 h at 100 V.
Chromosomal analysis by PFGE.
Genomic DNAs were prepared
using a slightly modified version of the procedure described by Taylor
et al. (43). Exponential-phase borreliae were washed with
50 mM Tris containing 150 mM NaCl buffer, pH 8.0 (TN), at 20°C
and were adjusted to an optical density of 1.5 at 600 nm in the same
buffer. A portion of this suspension was mixed with an equal volume of
molten 1.5% low-melting-temperature agarose (Bio-Rad) in TN buffer,
pipetted into 90-µl rectangular plug molds (Bio-Rad, Richmond,
Calif.), and then allowed to harden at 4°C for 15 min. The solidified
agarose plugs were immersed in a digestion solution of 50 mM Tris-50
mM EDTA-1% SDS (pH 8.0) and 1 µg of proteinase K (Boehringer
Mannheim) per ml and were incubated at 50°C for 16 to 24 h. The
plugs were then washed four times for 1 h with Tris-EDTA (10 mM
Tris-1.0 mM EDTA, pH 8.0) and stored at 4°C in the same buffer. Two
restriction endonucleases, MluI and SmaI, were
used to compare the different strains (Tables 1 and
2). For digestion, DNA
corresponding to half a plug was digested by incubation with 15 U of
the restriction enzymes, according to the manufacturer's instructions.
The plugs were then loaded onto 1% Pulsed Field Certified Agarose Gels
(Bio-Rad) in 0.25× Tris-borate-EDTA (TBE) (89 mM Tris-20 mM EDTA-89
mM boric acid, pH 8.3). PFGE was performed with a contour-clamped
homogeneous electric field apparatus (CHEF Mapper; Bio-Rad) at 14°C,
with buffer circulation and a constant voltage of 200 V. Runs were carried out with increasing pulse times (from 5 s to 15 s for 15 h and from 20 s to 25 s for 9 h). Gels were then
stained with ethidium bromide, destained in water, and photographed
under UV illumination.
SDS-PAGE.
Whole-cell lysates were prepared as described
elsewhere (11). Proteins were separated by SDS-PAGE using
Laemmli's buffer system and polyacrylamide gels (26);
molecular standards were run in each gel (SDS-PAGE Molecular Weight
Standards; Bio-Rad). After electrophoresis, gels were stained with
Coomassie brilliant blue.
 |
RESULTS |
Patients.
Of the 119 patients, 52 were female and 67 were
male; they ranged in age from 31 to 60 years. They all lived in or near
Belluno. All of them met the case definition for the public health
surveillance of LB of the U.S. Centers for Disease Control and
Prevention. All of the patients had an erythematous skin lesion,
whereas 19 of 119 (16%) of them had symptoms and/or signs suggestive
of systematic infection. None of the patients had arthritis. None of
them reported having been bitten by a tick bite outside the area of
Belluno, and none had received antibiotic treatment prior to clinical
diagnosis. Of the 119 skin specimens cultured for Borrelia,
55 (46%) were positive. Following diagnosis, all patients were
successfully treated with antibiotics.
Genetic typing of the isolates: PCR-RFLP analysis of the
rrfA-rrlB intergenic spacer.
Based
on the analysis of patterns obtained after restriction by
MseI, we were able to classify 41 of the 55 culture-positive samples. PCR amplification of the spacer region ranged from 216 to 226 bp. The patterns obtained after restriction by MseI were compared with the patterns reported by Postic et al. (36)
for each of the genospecies: the analysis of the amplicon patterns, reported in Fig. 1 for 30 of the 41 strains, revealed that the BL45 and BL47 strains belonged to B. burgdorferi sensu stricto and that BL21 and BL30 belonged to
B. garinii. BL44 showed a pattern with bands of both
B. burgdorferi sensu stricto and B. afzelii, and
consequently the isolate contained two distinct genospecies. The other
36 samples revealed a pattern identical to that of the VS461 strain and
were thus assigned to B. afzelii. Of these strains, four
(BL53, BL54, BL49, and BL34) showed an additional band of about 45 bp.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 1.
Typing of B. burgdorferi sensu lato
isolates by using rrfA-rrlB intergenic spacer PCR-RFLP
analysis. The rrfA-rrlB intergenic spacer was amplified
by PCR, and this was followed by the analysis of MseI
restriction polymorphism of PCR products. DNA was electrophoresed on a
16% acrylamide gel, stained with ethidium bromide, and UV illuminated.
The names of strains in each lane are indicated on the top of each well
in the photos. The molecular sizes of DNA fragments (in base pairs) are
shown on the right of the gels. Expected fragment sizes for B.
burgdorferi sensu stricto strains were 108, 50, 38, and 29 to
28 bp. Expected fragment sizes for B. garinii
strains were 108, 95, and 50 bp. Expected fragment sizes for B.
afzelii strains were 108, 68, 50, and 20 bp. The 20-bp expected
size was not easily visible.
|
|
PFGE analysis.
Of the 41 isolates typed by PCR-RFLP, which
were maintained for more than three passages in BSK medium, 13 were
further characterized by PFGE (i.e., BL11, BL12, BL21, BL25, BL29,
BL30, BL31, BL33, BL34, BL37, BL41, BL43, and BL48); the isolates were
cloned by limiting dilution method.
The genomic DNAs analyzed by PFGE after cleavage with the enzymes
MluI and
SmaI are shown in Fig.
2 and
3.
Additional strains,
belonging to
B. garinii and
B. burgdorferi sensu stricto,
B. afzelii,
B. valaisiana, and
B. lusitaniae, were used for comparison
purposes.
Since the bands smaller than 58 kb could be the result of
uncut
or cut plasmids, greater fragments were used to define
restriction
patterns. As expected, the strains analyzed using
MluI showed
five different restriction patterns
characteristic of the five
species (
9,
14), as shown in
Fig.
2.

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 2.
PFGE of MluI-cleaved genomic DNAs from
B. burgdorferi sensu lato strains. The digestion
products were separated at 200 V for 24 h in 1% agarose-0.25×
TBE with two increasing pulse times, from 5 to 15 s (15 h) and
from 20 to 25 s (9 h). The names of strains are indicated on the
top of each lane in the photos. M, size marker (108 bp). The molecular
sizes of DNA fragments (in kilobases) are shown on the left of the
gels. Reference strains and genospecies used were B31 and IRS, type
strains of B. burgdorferi sensu stricto; G25, type
strain of B. garinii; VS461, type strain of B.
afzelii; VS116, type strain of B. valaisiana;
and Poti B1, type strain of B. lusitaniae (A); and G25
and N34, type strains of B. garinii (B). An additional
band for BL43 is indicated by a small arrowhead.
|
|

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 3.
PFGE of SmaI-cleaved genomic DNAs from
B. burgdorferi sensu lato strains. The digestion
products were separated at 200 V for 24 h in 1% agarose-0.25×
TBE with two increasing pulse times as follows: from 5 to 15 s (15 h) and from 20 to 25 s (9 h). The names of strains are indicated
on the top of each lane in the photos. M, size marker ( ). The
molecular sizes of DNA fragments (in kilobases) are shown on the left
of the gels. Reference strains and genospecies used were B31 and IRS,
type strains of B. burgdorferi sensu stricto; G25, type
strain of B. garinii; VS461, type strain of B.
afzelii; VS116, type strain of B. valaisiana;
Poti B1, type strain of B. lusitaniae (A); and G25 and
N34, type strains of B. garinii (B). Additional bands
for BL12 and BL37 are indicated by small arrowheads.
|
|
The restriction patterns of
B. burgdorferi sensu stricto B31
showed three bands, at 418, 150, and 135 kb. These three bands
were
also found in the pattern of
B. burgdorferi IRS sensu
stricto,
which showed an additional band at 101 kb. The isolates BL21
and
BL30 (Fig.
2B), as well as strains N34 and G25, showed patterns
typical of the genospecies
B. garinii, consisting of two
bands
at 220 and 80 kb and three additional bands at 418, 100, and 63
kb, although the 63-kb band was not visible in strain BL21. A
band at
460 kb, instead of 418 kb, was detected in strain BZ5.
Thus, when
MluI was used, three patterns were observed for the
B. garinii strains: one included strains N34, G25, and the new
isolate BL30; a second pattern included the isolate BL21; and
a third
pattern included the strain BZ5. The remaining 11 isolates
(i.e., BL11,
BL12, BL25, BL29, BL31, BL33, BL34, BL37, BL41, BL43,
and BL48)
exhibited restriction patterns identical to that of
strain VS461,
consisting of three bands at 460, 320, and 90 kb,
confirming that they
belonged to
B. afzelii. Isolate BL43 showed
an additional
band at 60 kb. The type strains of
B. valaisiana and
B. lusitaniae each yielded a unique
MluI
restriction
pattern.
Like the patterns obtained with PFGE after
MluI digestion,
those obtained after
SmaI digestion (Fig.
3) allowed us to
differentiate
among the five
B. burgdorferi sensu lato
species on the basis
of characteristic bands and to identify BL21 and
BL30 as
B. garinii and the remaining 11 isolates as
B. afzelii. For fragments greater
than 58 kb, no differences in
restriction patterns were observed
in comparisons of BL21 and BL30.
Isolates BL21 and BL30 yielded
a
SmaI restriction pattern
that was indistinguishable from that
of G25 and N34 but distinct from
that of BZ5. Isolates BL11, BL25,
BL29, BL31, BL33, BL34, BL41, BL43,
and BL48 had restriction patterns
indistinguishable from that of VS461,
the type strain of
B. afzelii (Fig.
3A). The remaining two
isolates identified as
B. afzelii (BL12 and BL37) yielded
distinct
SmaI restriction patterns, which
were easily
distinguishable from that of VS461, as indicated by
arrows in Fig.
3A.
Protein profiles by SDS-PAGE.
The protein patterns of the 13 new isolates kept in culture were compared with those of the strains
used as controls. The overall protein patterns of BL21 and BL30 (Fig.
4A) were consistent with those for
B. garinii and were thus similar to those for strains N34
and G25; strain BZ5 differed from the other B. garinii
strains in that it had a higher molecular-mass-protein, OspA (33 kDa). The profiles of the isolates classified as B. afzelii were,
in general, similar to that of the B. afzelii strain VS461
(Fig. 4B). A certain degree of variability was evident in the protein size and level of expression of some B. afzelii isolates:
BL12 and BL37 differed in the relative migration of the protein band at
37 instead of 35 kDa, and strain BL12 displayed a higher expression of
the 23-kDa protein.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 4.
Coomassie brilliant blue-stained proteins in whole-cell
lysates of B. burgdorferi sensu lato strains. The names
of strains are indicated on the top of each lane in the photos. LMW,
low-molecular-weight standards; HMW, high-molecular-weight standards.
The molecular sizes of protein standards (in kilodaltons) are shown on
the right of the gels. Components were separated by SDS-PAGE
|
|
 |
DISCUSSION |
LB was first recognized in Italy in 1985 (18) and is
endemic in several regions. Most cases have been reported in northern Italy, and in the period from 1985 to 1996, only 6.1% of the cases were reported in central and southern Italy and the Islands. The review
of the national literature shows that, in the same 13-year period, at
least 368 cases were recorded in the region of Veneto (14), representing 27.8% of the cases reported nationwide
during this period.
Since the first LB case was described in 1985, the number of clinically
diagnosed cases in the Belluno Hospital has progressively increased: 15 cases in 1995, 45 in 1996, 85 in 1997, 75 in 1998, and 102 in 1999.
With regard to the isolation rate of B. burgdorferi, the
46% found in our study is quite high, although rates of B. burgdorferi in skin biopsy specimens have been reported to be as
high as 100% in Europe (10, 25, 32, 41).
The ribosomal DNA (rDNA) PCR-RFLP analysis showed that the majority of
the isolates belonged to B. afzelii; two isolates were classified as B. garinii and two as B. burgdorferi sensu stricto. Since the amplification was performed
on the first culture inoculated with the skin sample, we were able to
type all of the isolates, including those that did not subsequently
adapt to the BSK medium. In the case of isolate BL44, a hybrid profile
was obtained, which was interpreted as coinfection with B. afzelii and B. burgdorferi sensu stricto; this
phenomenon is quite common in the first isolation. The results of the
PFGE analysis of the 13 strains that were kept in culture, compared to
the strains of the five genospecies of B. burgdorferi sensu
lato and to the local tick strain BZ5, were consistent with the results
obtained with rDNA PCR-RFLP, yet they revealed heterogeneity within the
strains. In fact, we obtained three patterns within B. garinii strains by MluI digestion and two patterns by
SmaI digestion; even BL21 and BL30, though isolated in the
same restricted area of Belluno, differed for one band after digestion
with MluI. However, the BL30 strain showed a close relationship with G25, a Swedish tick isolate and N34. Strain BZ5 was
always shown to have a unique pattern. This heterogeneity within the
B. garinii genospecies was previously reported by other authors; in fact, Postic et al. (35, 39) described up to
four RFLPs in 20 B. garinii isolates. Although no
heterogeneity in the RFLP of B. afzelii strains has been
reported in the literature, we found two different patterns after
MluI digestion and three patterns after SmaI
digestion. These results demonstrate that strains that belong to the
same genomic species yet are characterized by different PFGE
restriction patterns may be present in a small geographic area. By
contrast, strains indistinguishable by their PFGE restriction patterns
can be found in geographically distant areas.
Our results show that in the small geographic area served by the
Belluno Hospital, the three main pathogenic genospecies of B. burgdorferi sensu lato are all present and that the dominant genospecies is B. afzelii; an analogous prevalence of this
genospecies has been reported in humans in Slovenia, which borders
northeastern Italy (34). The net prevalence of B. afzelii in human isolates in Belluno is quite unexpected if
compared to the genospecies prevalence rates in I. ricinus
ticks in the nearby region of Friuli Venezia Giulia (16).
In this region, the rate of infected ticks was 28% for B. burgdorferi sensu stricto, 13.2% for B. garinii, and
only 1.1% for B. afzelii. The majority of the ticks were
coinfected: 25.5% with B. burgdorferi sensu stricto and
B. garinii; 6.6% with B. burgdorferi sensu
stricto, B. garinii, and B. afzelii; and only
1.1% with B. burgdorferi sensu stricto and B. afzelii. There was thus a very low rate of tick infection by
B. afzelii alone or associated with other
Borrelia genospecies. In the rest of Europe, B. garinii appears to be prevalent, and B. afzelii
constitutes approximately 37% of B. burgdorferi sensu lato
isolates (23). The reasons for these discrepancies are
unknown, though the following hypotheses can be proposed: (i) There
exist local variations in the distribution of genomic species in Italy
due to the type of reservoirs; thus, there exists a true dominant
circulation of this genospecies in the Belluno area. (ii) All of our
isolates were from patients manifesting EM. Even though EM is the first lesion common to all LB manifestations, there is general agreement that
there is a preferential association of B. afzelii with
cutaneous manifestations and that the majority of isolates from EM and
acrodermatitis chronica athrophicans are B. afzelii
(4, 5, 40, 44).
In conclusion, our data contribute to the knowledge of the repartition
of the B. burgdorferi species in northern Italy, which is
important for the better use of antigens in serology and for defining
future vaccination policy.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Dipartimento di
Scienze Biomediche, Universita' di Trieste, 34127 Trieste, Italy.
Phone: 39 040 6767178. Fax: 39 040 351668. E-mail:
cinco{at}dsbmail.units.it.
 |
REFERENCES |
| 1.
|
Adam, T.,
G. S. Gassmann,
C. Rasiah, and U. B. Gobel.
1991.
Phenotypic and genotypic analysis of Borrelia burgdorferi isolates from various sources.
Infect. Immun.
59:2579-2585[Abstract/Free Full Text].
|
| 2.
|
Anthonissen, F. M.,
M. De Kesel,
P. P. Hoet, and G. H. Bigaignon.
1994.
Evidence for the involvement of different genospecies of Borrelia in the clinical outcome of Lyme disease in Belgium.
Res. Microbiol.
145:327-331[Medline].
|
| 3.
|
Assous, M. V.,
D. Postic,
G. Paul,
P. Nevot, and G. Baranton.
1994.
Individualisation of two genomic groups among American Borrelia burgdorferi sensu lato strains.
FEMS Microbiol. Lett.
121:261-268.
|
| 4.
|
Assous, M. V.,
D. Postic,
G. Paul,
P. Nevot, and G. Baranton.
1993.
Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens.
Eur. J. Clin. Microbiol. Infect. Dis.
12:261-268[CrossRef][Medline].
|
| 5.
|
Balmelli, T., and J. C. Pifferetti.
1995.
Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato.
Res. Microbiol.
146:329-340[Medline].
|
| 6.
|
Baranton, G.,
D. Postic,
I. Saint Girons,
P. Boerlin,
J. C. Piffaretti,
M. Assous, and P. A. D. Grimont.
1992.
Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.
Int. J. Syst. Bacteriol.
42:378-383[Abstract/Free Full Text].
|
| 7.
|
Barbour, A. G.
1988.
Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent.
J. Clin. Microbiol.
26:475-478[Abstract/Free Full Text].
|
| 8.
|
Barbour, A. G.
1984.
Isolation and cultivation of Lyme disease spirochete.
Yale J. Biol. Med.
57:521-525[Medline].
|
| 9.
|
Belfaiza, J.,
D. Postic,
E. Bellenger,
G. Baranton, and I. Saint Girons.
1993.
Genomic fingerprinting of Borrelia burgdorferi sensu lato by pulsed-field gel electrophoresis.
J. Clin. Microbiol.
31:2873-2877[Abstract/Free Full Text].
|
| 10.
|
Berger, B. W.,
R. C. Johnson,
C. Kodner, and L. Coleman.
1992.
Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin.
J. Clin. Microbiol.
30:359-361[Abstract/Free Full Text].
|
| 11.
|
Cacciapuoti, B.,
L. Ciceroni,
S. Ciarrocchi,
C. Khoury, and J. Simeoni.
1995.
Genetic and phenotypic characterization of Borrelia burgdorferi strains isolated from Ixodes ricinus ticks in the province of Bolzano, Italy.
Microbiologica
18:169-181[Medline].
|
| 12.
|
Canica, M. M.,
F. Nato,
L. du Merle,
J. C. Mazie,
G. Baranton, and D. Postic.
1993.
Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis.
Scand. J. Infect. Dis.
25:441-448[Medline].
|
| 13.
|
Caruso, G.,
C. Granata,
F. Guzzo,
V. Mondardini,
C. Zasio,
N. Papa,
E. Macri,
S. Ciarrocchi,
L. Ciceroni, and M. Cinco.
1999.
Attuali conoscenze sulla Borreliosi di Lyme e aspetti clinico-epidemiologici della malattia in Veneto.
G. Ital. Mal. Infett.
5(Suppl. 3):222-225.
|
| 14.
|
Ciceroni, L.,
S. Ciarrocchi, and J. Simeoni.
1998.
Antigenic and genomic analysis of a Borrelia burgdorferi sensu lato strain isolated from Ixodes ricinus ticks in Alto Adige-South Tyrol, Italy.
Eur. J. Epidemiol.
14:511-517[CrossRef][Medline].
|
| 15.
|
Cinco, M.,
R. De Giovannini,
P. Fattorini,
F. Florian, and G. Graziosi.
1993.
Classification of Italian isolates of Borrelia burgdorferi into three genomic groups.
Microbiologica
16:323-332[Medline].
|
| 16.
|
Cinco, M.,
D. Padovan,
R. Murgia,
L. Frusteri,
L. Poldini,
I. van de Pol,
K. N. Verbeek-De,
S. G. Rijpkema, and M. Maroli.
1998.
Rate of infection of Ixodes ricinus ticks with Borrelia burgdorferi sensu stricto. Borrelia garinii, Borrelia afzelii and group VS116 in an endemic focus of Lyme disease in Italy.
Eur. J. Clin. Microbiol. Infect. Dis.
17:90-94[Medline].
|
| 17.
|
Cinco, M.,
E. Banfi,
G. Trevisan, and G. Stanek.
1989.
Characterization of the first tick isolate of Borrelia burgdorferi from Italy.
APMIS
97:381-382[Medline].
|
| 18.
|
Crovato, F.,
G. Nazzari,
D. Fumarola,
G. Rovetta,
M. A. Cimmino, and G. Bianchi.
1985.
Lyme disease in Italy: first reported case.
Ann. Rheum. Dis.
44:570-571[Free Full Text].
|
| 19.
|
Fattorini, P.,
G. Graziosi,
D. Balanzin, and M. Cinco.
1991.
DNA homology comparison between American and European Borrelia burgdorferi strains.
FEMS Microbiol. Immunol.
3:13-18[CrossRef][Medline].
|
| 20.
|
Fukunaga, M.,
A. Hamase,
K. Okada, and M. Nakao.
1996.
Borrelia tanukii sp. nov. and Borrelia turdae sp. nov. found from ixodid ticks in Japan: rapid species identification by 16S rRNA gene-targeted PCR analysis.
Microbiol. Immunol.
40:877-881[Medline].
|
| 21.
|
Fukunaga, M.,
M. Sohnaka,
Y. Takahashi,
M. Nakao, and K. Miyanoto.
1993.
Antigenic and genetic characterization of Borrelia species isolated from Ixodes persulcatus in Hokkaido, Japan.
J. Clin. Microbiol.
31:1388-1391[Abstract/Free Full Text].
|
| 22.
|
Hermann, J. L., and I. Saint Girons.
1993.
Value of pulsed-field gel electroporesis for genetic and epidemiological studies of Leptospira and Borrelia.
Methods Mol. Cell. Biol.
4:63-67.
|
| 23.
|
Hubalek, Z., and J. Halouzka.
1997.
Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review.
Eur. J. Epidemiol.
13:951-957[CrossRef][Medline].
|
| 24.
|
Kawabata, H.,
T. Masuzawa, and Y. Yanagihara.
1993.
Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan.
Microbiol. Immunol.
37:843-848[Medline].
|
| 25.
|
Kuiper, H.,
A. P. van Dam,
L. Spanjaard,
B. M. de Jongh,
A. Vidjojokusumo,
T. C. Ramselaar,
I. Cairo,
K. Vos, and J. Dankert.
1994.
Isolation of Borrelia burgdorferi from biopsy specimens taken from healthy-looking skin of patients with Lyme borreliosis.
J. Clin. Microbiol.
32:715-720[Abstract/Free Full Text].
|
| 26.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London)
227:680-685[CrossRef][Medline].
|
| 27.
|
LeFebvre, R. B.,
G. C. Perng, and R. C. Johnson.
1989.
Characterization of Borrelia burgdorferi isolates by restriction endonuclease analysis and DNA hybridization.
J. Clin. Microbiol.
27:636-639[Abstract/Free Full Text].
|
| 28.
|
Le Fleche, A.,
D. Postic,
K. Girardet,
O. Peter, and G. Baranton.
1997.
Characterization of Borrelia lusitaniae sp. nov. by 16S ribosomal DNA sequence analysis.
Int. J. Syst. Bacteriol.
47:921-925[Abstract/Free Full Text].
|
| 29.
|
Livesley, M. A.,
I. P. Thompson,
L. Gern, and P. A. Nuttal.
1993.
Analysis of intra-specific variation in the fatty acid profiles of Borrelia burgdorferi.
J. Gen. Microbiol.
139:2197-2201[Abstract/Free Full Text].
|
| 30.
|
Marconi, R. T.,
D. Liveris, and I. Schwartz.
1995.
Identification of novel insertion elements, restriction fragment length polymorphism patterns, and discontinuous 23S rRNA in Lyme disease spirochetes: phylogenetic analyses of rRNA genes and their intergenic spacers in Borrelia japonica sp. nov. and genomic group 21038 (Borrelia andersonii sp. nov.) isolates.
J. Clin. Microbiol.
33:2427-2434[Abstract].
|
| 31.
|
Marconi, R. T., and C. F. Garon.
1992.
Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis.
J. Clin. Microbiol.
30:2830-2834[Abstract/Free Full Text].
|
| 32.
|
Mitchell, P. D.,
K. D. Reed,
M. F. Vandermause, and J. W. Melski.
1993.
Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans.
Am. J. Clin. Pathol.
99:104-107[Medline].
|
| 33.
|
Peter, O., and A. G. Bretz.
1992.
Polymorphism of outer surface proteins of Borrelia burgdorferi as a tool for classification.
Zentbl. Bakteriol.
277:28-33.
|
| 34.
|
Picken, R. N.,
Y. Cheng,
F. Strle,
J. Cimperman,
V. Maraspin,
S. Lotric-Furlan,
E. Ruzic-Sabljic,
D. Han,
J. A. Nelson,
M. M. Picken, and G. M. Trenholme.
1996.
Molecular characterization of Borrelia burgdorferi sensu lato from Slovenia revealing significant differences between tick and human isolates.
Eur. J. Clin. Microbiol. Infect. Dis.
15:313-323[CrossRef][Medline].
|
| 35.
|
Postic, D.,
J. Belfaiza,
E. Isogai,
I. Saint Girons,
P. A. D. Grimont, and G. Baranton.
1993.
A new genomic species in Borrelia burgdorferi sensu lato isolated from Japanese ticks.
Res. Microbiol.
144:467-473[Medline].
|
| 36.
|
Postic, D.,
M. V. Assous,
P. A. D. Grimont, and G. Baranton.
1994.
Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons.
Int. J. Syst. Bacteriol.
44:743-752[Abstract/Free Full Text].
|
| 37.
|
Postic, D.,
N. Marti Ras,
R. S. Lane,
M. Hendson, and G. Baranton.
1998.
Expanded diversity among Californian Borrelia isolates and description of Borrelia bissettii sp. nov. (formerly Borrelia group DN127).
J. Clin. Microbiol.
36:3497-3504[Abstract/Free Full Text].
|
| 38.
|
Postic, D.,
C. Edlinger,
C. Richaud,
F. Grimont,
Y. Dufresne,
P. Perolat,
G. Baranton, and P. A. D. Grimont.
1990.
Two genomic species in Borrelia burgdorferi.
Res. Microbiol.
141:465-475[Medline].
|
| 39.
|
Postic, D.,
E. Koremberg,
N. Gorelova,
Y. V. Kovalevski,
E. Bellenger, and G. Baranton.
1997.
Borrelia burgdorferi sensu lato in Russia and neighbouring countries: high incidence of mixed isolates.
Res. Microbiol.
148:691-702[Medline].
|
| 40.
|
Saint Girons, I.,
L. Gern,
J. S. Gray,
E. C. Guy,
E. Korenberg,
P. A. Nuttall,
S. G. Rijpkema,
A. Schonberg,
G. Stanek, and D. Postic.
1998.
Identification of Borrelia burgdorferi sensu lato species in Europe.
Zentbl. Bakteriol.
287:190-195.
|
| 41.
|
Schwartz, I.,
G. P. Wormser,
J. J. Schwartz,
D. Cooper,
P. Weissensee,
A. Gazumyan,
E. Zimmermann,
N. S. Golderberg,
S. Bittker,
G. L. Campbell, and C. S. Pavia.
1992.
Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions.
J. Clin. Microbiol.
30:3082-3088[Abstract/Free Full Text].
|
| 42.
|
Strle, F.,
R. N. Picken,
Y. Cheng,
J. Cimperman,
V. Maraspin,
S. Lotric-Furlan,
E. Ruzic-Sablich, and M. M. Picken.
1997.
Clinical findings for patients with Lyme borreliosis caused by Borrelia burgdorferi sensu lato with genotypic similarities to strain 25015.
Clin. Infect. Dis.
25:273-280[Medline].
|
| 43.
|
Taylor, K. A.,
A. G. Barbour, and D. D. Thomas.
1991.
Pulsed-field gel electrophoretic analysis of leptospiral DNA.
Infect. Immun.
59:323-329[Abstract/Free Full Text].
|
| 44.
|
Van Dam, A. P.,
H. Kuiper,
K. Vos,
A. Widjojokusumo,
B. M. De Jongh,
L. Spanjaard,
A. C. Ramselaar,
M. D. Kramer, and J. Dankert.
1993.
Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.
Clin. Infect. Dis.
17:708-717[Medline].
|
| 45.
|
Wang, G.,
A. P. van Dam,
A. Le Fleche,
D. Postic,
O. Peter,
G. Baranton,
R. de Boer,
L. Spanjaard, and J. Dankert.
1997.
Genetic and phenotypic analysis of Borrelia valaisiana sp. nov. (Borrelia genomic groups VS116 and M19).
Int. J. Syst. Bacteriol.
47:926-932[Abstract/Free Full Text].
|
| 46.
|
Welsh, J.,
C. Pretzman,
D. Postic,
I. Saint Girons,
G. Baranton, and M. McClelland.
1992.
Genomic fingerprinting by arbitrarily primed polymerase chain reaction resolves Borrelia burgdorferi into three distinct phyletic groups.
Int. J. Syst. Bacteriol.
42:370-377[Abstract/Free Full Text].
|
| 47.
|
Wilske, B.,
V. Preac-Mursic,
U. B. Gobel,
B. Graf,
S. Jauris,
E. Soutschek,
E. Schwab, and G. Zumstein.
1993.
An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.
J. Clin. Microbiol.
31:340-350[Abstract/Free Full Text].
|
| 48.
|
Wilske, B.,
S. Jauris-Heipke,
R. Lobentanzer,
I. Pradel,
V. Preac-Mursic,
D. Rossler,
E. Soutschek, and R. C. Johnson.
1995.
Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.
J. Clin. Microbiol.
33:103-109[Abstract].
|
Journal of Clinical Microbiology, June 2001, p. 2254-2260, Vol. 39, No. 6
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.6.2254-2260.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Marangoni, A., Sambri, V., Accardo, S., Cavrini, F., Mondardini, V., Moroni, A., Storni, E., Cevenini, R.
(2006). A Decrease in the Immunoglobulin G Antibody Response against the VlsE Protein of Borrelia burgdorferi Sensu Lato Correlates with the Resolution of Clinical Signs in Antibiotic-Treated Patients with Early Lyme Disease. CVI
13: 525-529
[Abstract]
[Full Text]
-
Marangoni, A., Sparacino, M., Cavrini, F., Storni, E., Mondardini, V., Sambri, V., Cevenini, R.
(2005). Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy. J Med Microbiol
54: 361-367
[Abstract]
[Full Text]